---
figid: PMC7216265__ijms-21-02872-g002
figlink: pmc/articles/PMC7216265/figure/ijms-21-02872-f002/
number: F2
caption: miRNAs affect glutaminolysis in cancer. Several miRNAs regulate proteins
  involved in transport or metabolism of glutamine. GLS is regulated by miR-122, -203,
  -23b, -23a, -513c, -153 and -137; while, miR-103-3p regulates GLS2. Moreover, miR-140-5p
  negatively regulates GS expression. GOT1 protein is posttranscriptional affected
  by miR-9 and -9-5p, while transporter ASCT2 translation is decreased via miR-122
  and -137. Autophagy components such as autophagy related 13 and 8 (ATG13, ATG8)
  are suppressed through miR-133a-3p, blocking glutamine recycling. Additionally,
  the c-Myc transcription factor is inhibited by miR-145, affecting the expression
  of its targets, including GLS, ASCT, SNAT5, LAT1, miR-105, miR-23b and -23a. Furthermore,
  cancer cells secrete miR-105 in the extracellular vesicles (EV) reaching cancer-associated
  fibroblasts (CAF), where miR-105 promotes MAX interactor 1 (MXI1) mRNA degradation
  and subsequently induces the activation of glutaminolysis-related genes through
  the c-Myc/c-Myc associated factor X (MAX) transcriptional complex. Finally, p65
  and methyl-CpG binding protein (MeCP2)/DNA methyltransferase (DNMT) negatively regulate
  miR-23a and miR-137, respectively, affecting the glutaminolysis pathway.
pmcid: PMC7216265
papertitle: Non-Coding RNAs as Key Regulators of Glutaminolysis in Cancer.
reftext: Yunuen Ortiz-Pedraza, et al. Int J Mol Sci. 2020 Apr;21(8):2872.
pmc_ranked_result_index: '69190'
pathway_score: 0.9470462
filename: ijms-21-02872-g002.jpg
figtitle: miRNAs affect glutaminolysis in cancer
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7216265__ijms-21-02872-g002.html
  '@type': Dataset
  description: miRNAs affect glutaminolysis in cancer. Several miRNAs regulate proteins
    involved in transport or metabolism of glutamine. GLS is regulated by miR-122,
    -203, -23b, -23a, -513c, -153 and -137; while, miR-103-3p regulates GLS2. Moreover,
    miR-140-5p negatively regulates GS expression. GOT1 protein is posttranscriptional
    affected by miR-9 and -9-5p, while transporter ASCT2 translation is decreased
    via miR-122 and -137. Autophagy components such as autophagy related 13 and 8
    (ATG13, ATG8) are suppressed through miR-133a-3p, blocking glutamine recycling.
    Additionally, the c-Myc transcription factor is inhibited by miR-145, affecting
    the expression of its targets, including GLS, ASCT, SNAT5, LAT1, miR-105, miR-23b
    and -23a. Furthermore, cancer cells secrete miR-105 in the extracellular vesicles
    (EV) reaching cancer-associated fibroblasts (CAF), where miR-105 promotes MAX
    interactor 1 (MXI1) mRNA degradation and subsequently induces the activation of
    glutaminolysis-related genes through the c-Myc/c-Myc associated factor X (MAX)
    transcriptional complex. Finally, p65 and methyl-CpG binding protein (MeCP2)/DNA
    methyltransferase (DNMT) negatively regulate miR-23a and miR-137, respectively,
    affecting the glutaminolysis pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GLS
  - SLC1A5
  - H6PD
  - MXI1
  - MYC
  - MAX
  - GLS2
  - ATG13
  - GABARAPL2
  - ACO2
  - DNMT1
  - MECP2
  - CAF
  - Glutamine
  - Glutamate
  - Aspartate
  - TCA
  - Citrate
  - Isocitrate
  - Acetyl-CoA
  - GS
  - Cancer
genes:
- word: GLS
  symbol: GLS
  source: hgnc_symbol
  hgnc_symbol: GLS
  entrez: '2744'
- word: ASCT2
  symbol: ASCT2
  source: hgnc_alias_symbol
  hgnc_symbol: SLC1A5
  entrez: '6510'
- word: GDH
  symbol: GDH
  source: hgnc_prev_symbol
  hgnc_symbol: H6PD
  entrez: '9563'
- word: MXI
  symbol: MXI
  source: hgnc_alias_symbol
  hgnc_symbol: MXI1
  entrez: '4601'
- word: C-Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: MAX
  symbol: MAX
  source: hgnc_symbol
  hgnc_symbol: MAX
  entrez: '4149'
- word: GLS
  symbol: GLS
  source: hgnc_symbol
  hgnc_symbol: GLS
  entrez: '2744'
- word: GLS2
  symbol: GLS2
  source: hgnc_symbol
  hgnc_symbol: GLS2
  entrez: '27165'
- word: ATG13
  symbol: ATG13
  source: hgnc_symbol
  hgnc_symbol: ATG13
  entrez: '9776'
- word: ATG8
  symbol: ATG8
  source: hgnc_alias_symbol
  hgnc_symbol: GABARAPL2
  entrez: '11345'
- word: ACO2
  symbol: ACO2
  source: hgnc_symbol
  hgnc_symbol: ACO2
  entrez: '50'
- word: DNMT
  symbol: DNMT
  source: hgnc_prev_symbol
  hgnc_symbol: DNMT1
  entrez: '1786'
- word: MECP2
  symbol: MECP2
  source: hgnc_symbol
  hgnc_symbol: MECP2
  entrez: '4204'
- word: C-Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: GLS
  symbol: GLS
  source: hgnc_symbol
  hgnc_symbol: GLS
  entrez: '2744'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: ASCT2
  symbol: ASCT2
  source: hgnc_alias_symbol
  hgnc_symbol: SLC1A5
  entrez: '6510'
- word: SLC1A5
  symbol: SLC1A5
  source: hgnc_symbol
  hgnc_symbol: SLC1A5
  entrez: '6510'
chemicals:
- word: CAF
  source: MESH
  identifier: C035000
- word: Glutamine
  source: MESH
  identifier: C578860
- word: Glutamate
  source: ''
  identifier: ''
- word: Aspartate
  source: ''
  identifier: ''
- word: TCA
  source: MESH
  identifier: C000589078
- word: Citrate
  source: MESH
  identifier: C102006
- word: Isocitrate
  source: MESH
  identifier: D007523
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
diseases:
- word: GS
  source: MESH
  identifier: D011125
- word: Cancer
  source: MESH
  identifier: D009369
figid_alias: PMC7216265__F2
redirect_from: /figures/PMC7216265__F2
figtype: Figure
---
